Literature DB >> 13058274

Comparative effects of ACTH and butazolidin in rheumatoid arthritis.

R M MASON.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; ANALGESICS/therapeutic use; ARTHRITIS, RHEUMATOID/therapy

Mesh:

Substances:

Year:  1953        PMID: 13058274      PMCID: PMC1030461          DOI: 10.1136/ard.12.2.82

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Observations on the use of butazolidin in arthritis.

Authors:  H R DAVIES; R W BARTER; A GEE; C HIRSON
Journal:  Br Med J       Date:  1952-12-27

2.  Phenylbutazone therapy of arthritis and other painful musculoskeletal disorders.

Authors:  O STEINBROCKER; S BERKOWITZ; M EHRLICH; M ELKIND; S CARP
Journal:  J Am Med Assoc       Date:  1952-11-15

3.  Clinical "assay" of corticotrophin; preliminary comparison of methods.

Authors:  B M ANSELL; E G L BYWATERS
Journal:  Ann Rheum Dis       Date:  1952-09       Impact factor: 19.103

4.  Responsiveness to ACTH and cortisone in rheumatoid arthritis.

Authors:  J H KELLGREN; O JANUS; R MOORE; D S JACKSON
Journal:  Br Med J       Date:  1952-05-10

5.  Measurement of digital swelling in rheumatoid arthritis.

Authors:  F D HART; C J M CLARK
Journal:  Lancet       Date:  1951-04-07       Impact factor: 79.321

6.  Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.

Authors:  W C KUZELL; R W SCHAFFARZICK; B BROWN; E A MANKLE
Journal:  J Am Med Assoc       Date:  1952-06-21

7.  Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.

Authors:  C A L STEPHENS; E E YEOMAN; W P HOLBROOK; D F HILL; W L GOODIN
Journal:  J Am Med Assoc       Date:  1952-11-15
  7 in total
  2 in total

1.  Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation.

Authors:  R BARCELO; C LEBLANC; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-23       Impact factor: 8.262

2.  Effects of oxyphenbutazone (Tandearil) on plasma seromucoids. I. In experimental inflammation.

Authors:  R BARCELO; P RIOPEL; L P LEGRESLEY
Journal:  Can Med Assoc J       Date:  1963-03-16       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.